Rivaroxaban Bluefish 15 mg film-coated tablets EFG
Rivaroxaban Bluefish 20 mg film-coated tablets EFG
Read the entire leaflet carefully before starting to take this medicine, as it contains important information for you.
Contents of the pack
Rivaroxaban Bluefish contains the active substance rivaroxaban. Rivaroxaban is used in adults to:
Rivaroxaban is used in children and adolescents under 18 years of age and with a body weight of 30 kg or more to:
Rivaroxaban belongs to a group of medicines called antithrombotic agents. It works by blocking a factor involved in blood clotting (factor Xa) and thus reducing the tendency of blood to form clots.
Do not take Rivaroxaban Bluefish
Do not take Rivaroxaban Bluefish and inform your doctorif any of these circumstances apply to you.
Warnings and precautions
Consult your doctor or pharmacist before starting to take rivaroxaban.
Be careful with Rivaroxaban Bluefish
Inform your doctor if you have any of these conditionsbefore taking rivaroxaban. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If you need surgery
Children and adolescents
Rivaroxaban is not recommended in children with a body weight below 30 kg. There is not enough information about the use of rivaroxaban in children and adolescents for adult indications.
Other medicines and Rivaroxaban Bluefish
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine, including those obtained without a prescription.
If any of the above circumstances apply to you, inform your doctorbefore taking rivaroxaban, as the effect of rivaroxaban may be increased. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing a stomach or intestinal ulcer, they may recommend that you also use a preventive treatment.
If any of the above circumstances apply to you, inform your doctorbefore taking rivaroxaban, as the effect of rivaroxaban may be reduced. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
Pregnancy and breastfeeding
Do not take rivaroxaban if you are pregnant or breastfeeding. If there is any possibility that you may become pregnant, use a reliable contraceptive while taking rivaroxaban. If you become pregnant while taking this medicine, inform your doctor immediately, who will decide how you should be treated.
Driving and using machines
Rivaroxaban may cause dizziness (common side effect) or fainting (uncommon side effect) (see section 4 "Possible side effects"). You should not drive, ride a bicycle, or use tools or machines if you are affected by these symptoms.
Rivaroxaban Bluefish contains lactose and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially, "sodium-free".
Follow the instructions for administration of this medicine exactly as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
You should take rivaroxaban with food. Swallow the tablets, preferably with water.
If you have difficulty swallowing the tablet whole, consult your doctor about other ways to take rivaroxaban. The tablet can be crushed and mixed with water or apple sauce, immediately before taking it. Then, take food.
If necessary, your doctor may also administer the crushed rivaroxaban tablet through a gastric tube.
What dose to take
If you have kidney problems, the dose may be reduced to one 15 mg rivaroxaban tablet once a day.
If you need to undergo a procedure to treat blocked blood vessels in your heart (called percutaneous coronary intervention - PCI with stent placement), there is limited evidence to reduce the dose to one 15 mg rivaroxaban tablet once a day (or one 10 mg rivaroxaban tablet once a day if your kidneys do not function properly) in addition to an antiplatelet medicine such as clopidogrel.
The recommended dose is one 15 mg rivaroxaban tablet twice a day for the first 3 weeks. For treatment after 3 weeks, the recommended dose is one 20 mg rivaroxaban tablet once a day.
After at least 6 months of treatment for blood clots, your doctor may decide to continue treatment with one 10 mg rivaroxaban tablet once a day or one 20 mg rivaroxaban tablet once a day.
If you have kidney problems and are taking one 20 mg rivaroxaban tablet once a day, your doctor may decide to reduce the treatment dose to one 15 mg rivaroxaban tablet once a day after 3 weeks if the risk of bleeding is higher than the risk of having another blood clot.
The dose of rivaroxaban depends on body weight and will be calculated by your doctor.
Take each dose of rivaroxaban with a drink (e.g., water or juice) during a meal. Take the tablets every day at approximately the same time. Consider setting an alarm to remind you.
For parents or caregivers: observe the child to ensure they take the entire dose.
Since the dose of rivaroxaban is based on body weight, it is essential to attend scheduled visits with your doctor, as it may be necessary to adjust the dose as weight changes.
Never adjust the dose of rivaroxaban on your own. Your doctor will adjust the dose if necessary.
Do not divide the tablet to try to obtain a fraction of the tablet dose. If a smaller dose is required, other pharmaceutical forms are available.
In children and adolescents who cannot swallow the tablets whole, please use another pharmaceutical form.
If other pharmaceutical forms are not available, you can crush the rivaroxaban tablet and mix it with water or apple sauce immediately before taking it. Take some food after taking this mixture. If necessary, your doctor may also administer the crushed rivaroxaban tablet through a gastric tube.
If you spit up the dose or vomit
Call your doctor if you spit up the dose or vomit repeatedly after taking rivaroxaban.
When to take Rivaroxaban Bluefish
Take the tablets every day until your doctor tells you to stop.
Try to take the tablets at the same time every day to remember when to take them. Your doctor will decide how long you should continue taking the treatment.
To prevent blood clots in the brain (stroke) or in other blood vessels: If it is necessary to normalize your heartbeat through a procedure called cardioversion, take rivaroxaban at the times indicated by your doctor.
If you forget to take Rivaroxaban Bluefish
If you are taking one 20 mg or one 15 mg tablet oncea day and you forget a dose, take it as soon as you remember. Do not take more than one tablet in a single day to make up for a forgotten dose. Take the next tablet the next day and then continue taking one tablet every day.
If you are taking one 15 mg tablet twicea day and you forget a dose, take it as soon as you remember. Do not take more than two 15 mg tablets in a single day. If you forget a dose, you can take two 15 mg tablets at the same time, for a total of two tablets (30 mg) in a day. The next day, you should continue taking one 15 mg tablet twice a day.
If you take more Rivaroxaban Bluefish than you should
Call your doctor immediately if you have taken too many rivaroxaban tablets. Taking too much rivaroxaban increases the risk of bleeding.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you stop taking Rivaroxaban Bluefish
Do not stop taking rivaroxaban without consulting your doctor first, as rivaroxaban treats and prevents serious conditions.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, rivaroxaban can cause adverse effects, although not all people suffer from them.
Like other similar medicines to reduce blood clot formation, rivaroxaban can cause bleeding that can put the patient's life at risk. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be evident.
Inform your doctor immediately if you experience any of the following symptoms:
Your doctor may decide to keep you under closer observation or change your treatment.
The frequency of these adverse effects is very rare (up to 1 in 10,000 people).
Severe allergic reactions are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible adverse effects found in adults, children, and adolescents
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(frequency cannot be estimated from available data)
Adverse effects in children and adolescents
In general, the adverse effects observed in children and adolescents treated with rivaroxaban were similar to those observed in adults and their severity was mainly mild to moderate.
Adverse effects that were more frequently observed in children and adolescents:
Very frequent(may affect more than 1 in 10 people)
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging and on each blister or vial after "CAD" or "EXP".
The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Crushed tablets
Crushed tablets are stable in water or apple puree for up to 4 hours.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines that you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines that you no longer need. This way, you will help protect the environment.
Composition of Rivaroxaban Bluefish
Tablet core: microcrystalline cellulose, sodium croscarmellose, lactose monohydrate, hypromellose, sodium lauryl sulfate, magnesium stearate.
Tablet film coating: macrogol, hypromellose, titanium dioxide (E 171), red iron oxide (E 172).
Appearance of the product and package contents
Rivaroxaban Bluefish 15 mg film-coated tablets are biconvex, round, red tablets, marked with "1" on one face and with a diameter of approximately 5 mm.
Rivaroxaban Bluefish 20 mg film-coated tablets are biconvex, round, reddish-brown tablets, marked with a "2" on one face and with a diameter of approximately 6 mm.
The tablets are packaged in PVC/PVdC//Al blisters.
Package sizes of 15 mg: 10, 14, 28, 30, 42, 98, and 100 tablets
Package sizes of 20 mg: 10, 28, 30, 98, and 100 tablets
Not all package sizes may be marketed.
Marketing authorization holder
Bluefish Pharmaceuticals AB
P.O. Box 49013
100 28 Stockholm
Sweden
Manufacturer
Sofarimex-Indústria Química e Farmacêutica, S.A.
Avenida das Indústrias, Alto de Colaride,
2735-213 Cacém, Portugal.
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Bluefish Pharma S.L.U.,
AP 36007, 2832094 Madrid,
Sucursal 36
This medicine is authorized in other EEA countries with the following names:
Germany | Rivaroxaban Bluefish 15 mg/20 mg film-coated tablets |
Austria | Rivaroxaban Bluefish 15 mg/20 mg film-coated tablets |
Denmark | Rivaroxaban Bluefish 15 mg/20 mg film-coated tablets |
Spain | Rivaroxaban Bluefish 15 mg film-coated tablets EFG Rivaroxaban Bluefish 20 mg film-coated tablets EFG |
France | Rivaroxaban Bluefish 15 mg/20 mg film-coated tablets |
Ireland | Rivaroxaban Bluefish 15 mg/20 mg film-coated tablets |
Iceland | Rivaroxaban Bluefish 15 mg/20 mg film-coated tablets |
Norway | Rivaroxaban Bluefish 15 mg/20 mg film-coated tablets |
Poland | Rivaroxaban Bluefish |
Portugal | Rivaroxaban Bluefish |
United Kingdom (NI) | Rivaroxaban Bluefish 15 mg/20 mg film-coated tablets |
Sweden | Rivaroxaban Bluefish |
Date of the last revision of this prospectus:January 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).